Featured Genomics Experts

Dr. Roshan Daniel is a Clinical Geneticist based in Thiruvananthapuram, Kerala, where he independently heads the Department of Medical Genetics and Precision Medicine at KIMSHealth, one of Kerala's largest and most respected hospital groups. He is the founder of Genetidoc, India's largest network of online genetics specialists, built to make expert genetic care accessible, affordable, and personal for families across the country. He completed his Doctor of Medicine (MD) in Pediatrics and his Doctorate of Medicine (DM) in Medical Genetics at the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh — one of India's most prestigious postgraduate medical institutions. In 2025, he earned the European Board of Medical Genetics and Genomics (ECMGG) certification and a Postgraduate Diploma in Precision Oncology, placing him among a small group of Indian geneticists with formal recognition at an international standard. Dr. Daniel's clinical philosophy centres on translating high-end genomic science into actionable, human-centred care — whether guiding a previvor (a person at high genetic risk for cancer) through risk management, resolving a complex paediatric diagnostic case, or helping a couple navigate their reproductive options. He is an author of peer-reviewed publications on rare mitochondrial disorders, Schwartz–Jampel Syndrome, and RASopathies, and is an active mentor to clinicians and medical students through workshops, webinars, and structured coaching programmes. Areas of Expertise Precision Oncology and Hereditary Cancer Integration of genomic insights for personalised cancer risk assessment, surveillance, and management, including care for previvors navigating hereditary cancer syndromes such as BRCA-related cancers and Lynch syndrome. Reproductive and Prenatal Genetics Specialist genetic testing and counselling for congenital anomalies, high-risk pregnancies, and preconception planning. Paediatric Rare Diseases Diagnosis and management of syndromic conditions, developmental delays, and skeletal dysplasias in children, developed across years of practice at a tertiary genetics centre. Neurometabolic Disorders and Neurogenetics Evaluation and management of hereditary neurological conditions across paediatric and adult populations, including complex metabolic presentations with neurological involvement.

With a PhD in molecular genetics and as a specialist in data science, Céline Chantry-Darmon has over twenty years of experience in biomedical research and complex data analysis. As Scientific Director at Tekkare, she works on developing trustworthy artificial intelligence for healthcare. She is also committed to promoting inclusive and responsible artificial intelligence, and to advancing women in science and technology.

Ryan Farmer is the founder of My Peptide Match, a consumer education site that helps people make sense of GLP-1 medications and the fast-changing peptide landscape. He focuses on simplifying complex topics—like real-world pricing, treatment pathways, sourcing differences, and what questions to ask—so readers can make more informed decisions with their clinician. Ryan tracks emerging trends across weight-loss peptides, compounding and telehealth access, and the economics that shape what consumers actually pay. He’s available to comment on GLP-1 and peptide cost comparisons, patient decision-making, and the broader market shifts driving demand. He also publishes practical reference tools, including a peptide calculator and dosage guide, to support clearer conversations between consumers and providers.

Dr. James Utley is a pioneering scientist at the forefront of cellular therapy, AI, and data science. A Johns Hopkins-educated Immunohematology expert and Certified Advanced Biotherapies Professional (CABP), he also holds advanced certifications in data science and machine learning. While serving as Technical Director at a major healthcare organization, Dr. Utley oversaw more than 150,000 successful cellular transfusions and spearheaded advancements that significantly improved patient outcomes. This experience included leading initiatives for the Department of Defense, where he revolutionized cellular transfusion practices. His innovative approach is further exemplified by his FDA-approved work and numerous publications in leading scientific journals. Dr. Utley is also known for his bold, hands-on approach to research, embodying the spirit of a "biohacker" by pushing the boundaries of CRISPR and genetic engineering through self-experimentation. This unique blend of rigorous scientific training and unconventional methods has earned him the moniker "the pirate" within the biohacker community.

R.G.C.C. International GmbH is a leading company in analysis of circulating tumor cells as well as Cancer Stem Cells.Through our high quality analysis at R.G.C.C. International GmbH we are able to offer a full ranges of services to the R & D, clinical, and pharmaceutical industry.By using the most advanced and innovative technologies of molecular and cellular

Highly motivated certified genetic counselor with 1.5+ years of clinical experience in oncology. Specialties include: patient care in cancer genetics, science writing/communication and clinical research.

Independent neuroscience researcher and founder of PinealCode.com, where I publish evidence-based articles on pineal gland health, sleep science, and supplementation. My work covers fluoride accumulation in brain tissue, melatonin biochemistry, calcification mechanisms, and supplement efficacy — all referenced against primary literature from PubMed, NIH, Nature, and BMJ. Available to comment on brain health, sleep disorders, detoxification protocols, and the science behind popular wellness claims.

Founder of IngredientMD, a supplement intelligence platform powdered by most clinical data available. What's important, we communicate in language humans will understand instead. It all starts from individual ingredients instead of product name, claims, and anything else. Product is what's inside instead of what perception is being made. In our analysis of 500+ supplement products, we found 42% had at least one key ingredient below clinically studied doses. I focus on bringing evidence-based analysis to consumer supplement decisions.

Emanuele Andreano is an immunologist and biotech innovator redefining how vaccines are discovered for pandemic threats. As Head of Serology and Immunology at the Fondazione Biotecnopolo di Siena and a leader in the European Vaccine Hub, he works at the intersection of AI, immunology, and global health. He pioneered Reverse Vaccinology 3.0, a breakthrough approach that can identify entirely new vaccine targets in days instead of years. In a first-of-its-kind demonstration, his team showed that artificial intelligence can predict unknown viral antigens directly from human antibody sequences—effectively reversing the traditional vaccine discovery process. His work spans monoclonal antibody discovery and next-generation vaccines against emerging pathogens, including mpox and SARS-CoV-2, with direct implications for global pandemic preparedness and biosecurity. Andreano has received international recognition, including the Antonio Feltrinelli Prize from the Accademia Nazionale dei Lincei, awarded in the presence of the President of the Italian Republic Sergio Mattarella, the IUIS Rising Star in Immunology, and a European Research Council (ERC) grant. He also co-directs a vaccinology program at the Institut Pasteur in Paris. “We are entering an era where vaccines can be discovered at unprecedented speed—transforming our ability to fight pandemics and save countless lives.”

Clinical trial management of two stem cell clinical trials. I have a passion for data science analytics and rigorous pattern-seeking. I believe in leading from the front and making sure the team is well taken care of. *Managing 2 stem cell clinical trials, NCT02838316 and NCT05421689*30 peer-reviewed publications.*>12,000 citations.*2 provisional patents.*Co-founded startup.*Co-developed departmental leadership program.*Strong track record of grant funding and collaboration building.* Associated Editor for two flagship scientific journals (Stem Cells, Journal of Extracellular Biology).GOOGLE SCHOLAR PROFILEhttps://scholar.google.com/citations?user=3uQtjEEAAAAJ&hl=en

An Engineer by education, Finance professional by experience, Entrepreneur at heart. Enjoy the Startup-To-Scale Journey. Forever optimist.

James Bean is a pioneering cannabis industry expert and Founding CEO of Seeds Here Now, the longest continuously operating seed bank in the United States with 15 years of proven leadership. Since 2010, Bean has built an industry-leading catalog featuring 3,500+ strains from 80+ world-class breeders, establishing Seeds Here Now as the premier destination for authentic cannabis genetics. With a Plant Science degree from Oaksterdam University and 15 years specializing in cannabis genetics, Bean brings unparalleled expertise in breeder verification, genetic authenticity, and cultivation science. His knowledge spans feminized, regular, and autoflower seed production, pheno-hunting, breeding practices, and strain lineage documentation. Bean's industry authority is demonstrated through extensive media presence on major cannabis podcasts including The Adam Dunn Show (as "James Bean Man on the Scene"), The Dude Grows Show, The Pot Cast, and Grow Bud Yourself Podcast. He has personally vended at hundreds of cannabis trade shows including High Times Cannabis Cups and Canna Con events, and serves as a cannabis competition judge. As a heavy cannabis consumer with decades of personal experience, Bean possesses exceptional first-hand knowledge of strain effects and quality assessment. His business has served thousands of satisfied customers with germination guarantees and transparent practices, earning recognition including the 2023 Leafly Seed Bank Hall of Fame honor and Forbes media coverage. Bean actively supports cannabis community causes, mentors emerging businesses, and contributes educational content through articles and podcast appearances. His direct relationships with renowned breeders like TH Seeds, Exotic Genetics, La Plata Labs, Snow High Seeds, and Dominion Seed Company underscore his trusted position as the "#1 U.S. Broker of High Quality Cannabis Genetics." Based in Tulsa, Oklahoma, Bean continues to shape cannabis breeding trends, preserve rare genetics, and advance industry professionalism while maintaining Seeds Here Now's position as America's most trusted source for authentic cannabis seeds.

Dr. Robert Abraham is a regenerative medicine consultant and healthcare strategy advisor with more than a decade of experience operating multi-location healthcare practices. He earned his Bachelor of Science in Health Sciences and Biology from the University of Central Florida before pursuing advanced training in clinical operations and regenerative-focused program development. Based in Florida, Dr. Abraham has worked with healthcare organizations throughout the Orlando region and nationwide, advising clinics on structured implementation, operational systems design, revenue forecasting, and compliance-conscious growth within regenerative medicine and wound care services. In addition to his consulting work, he serves as Chief Executive Officer of Cross Biotech, a biologics distribution company supporting providers in aligning product access with disciplined operational frameworks. His work emphasizes infrastructure-driven expansion, leadership accountability, and sustainable healthcare systems.

I am an entrepreneur in the medical industry working on creating a new way to approach healthcare and wellness. The company is called Selph, it is a healthcare revolution to provide individuals with the tools to optimise their health. I am a trained General Practitioner and prior to my medical training I completed a PhD looking at the impact of nutrition and probiotic supplementation on metabolism and the developing immune system. I am fascinated by the interaction between the microbiome and health and was a past member of the science translational committee for the International Scientific Association for Probiotics and Prebiotics as well as a founding member of the International Cancer Microbiome Consortium. During my clinical training I became excited in the importance of the mind in physical health and vice versa and so I trained as an accredited mindfulness teacher specialising in mindfulness for stress and mindfulness for chronic pain.

Dr. Prashant Singh is an Associate Professor at Florida State University (FSU) and a food safety microbiologist by training, with his core area of research focus on the development of rapid methods for the detection of foodborne pathogens. His laboratory focuses explicitly on developing methods for the specific detection of virulent strains of Shiga toxin-producing non-O157 Escherichia coli and Salmonella. His second area of research interest is the development of rapid methods for seafood species identification. As a scientific advisor to SeaD Consulting, Dr. Singh developed an assay standardized in a study that “showed 100% sensitivity and specificity” for confirming the identity of shrimp. The Rapid ID Genetic Hi-accuracy Test (RIGHTTest), provides a “simple and accurate DNA-based solution for the onsite identification” of shrimp species. The cost-effective and reliable solution for the food industry’s onsite DNA-based testing needs is effective in both cooked and raw shrimp. With the assay test, users should be able to confirm the species of shrimp being offered for sale using a hand-held device in just two hours without having to send samples to a commercial testing laboratory.

Ilya J. Finkelstein, PhD is a Professor of Molecular Biosciences at The University of Texas at Austin specializing in gene editing, biophysics, and biotechnology. He has published 100+ peer-reviewed papers, holds multiple patents, and has served as an expert witness and technical consultant. His work appears frequently in scientific and popular press.

As I am a medical expert for Invigor Medical, a urologist, and an MD currently completing my PhD in clinical medicine, my work bridges patient care, education, and research. I serve as a teaching assistant in surgery, where I guide and support future doctors while treating patients in everyday practice. My research focuses on oncologic urology, men’s health, and hormonal health, and I actively collaborate on international studies. Through these roles, I am dedicated to advancing evidence-based medicine, improving patient outcomes, and helping shape the future of urological care.

Founder of Peptides.io, an independent educational platform dedicated to making peptide research easier to understand. I focus on translating peer-reviewed science into practical, evidence-based content covering longevity, metabolic health, recovery, weight management, and emerging peptide therapies. My work emphasizes transparency, critical evaluation of research, and helping readers separate evidence from marketing claims. Peptides.io does not provide medical advice or sell peptides—we aim to make complex research more accessible and understandable.

I am an MD-PhD physician-scientist with a passion for translating complex clinical and scientific data into clear, accurate content. My training and experience span clinical practice and translational research, with expertise across oncology, immunology, gastroenterology, inflammation & metabolism, and rare diseases. With over 10 years of experience, I have supported key deliverables including more than 30 peer-reviewed publications, manuscripts, slide decks, literature reviews, and scientific narratives. I enjoy working in collaborative, deadline-driven environments and am particularly interested in medical writing, medical information, and publication development, where scientific accuracy and effective storytelling intersect.

I'm a dedicated plant research scientist with a deep passion for harnessing the power of science and technology to enhance the field of agriculture. I am an expert in the development of Integrated Pest Management (IPM) strategies aimed at combating diseases in vegetable and fruit crops, both within the greenhouse and field environment, for improved productivity.I find great satisfaction in sharing my extensive agronomic knowledge and promoting agriculture products and services with different stakeholders.